Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Adam Silverman Group Leader Protein Engineering at Denali Therapeutics


Adam P. Silverman is the Group Leader for Protein Engineering at Denali Therapeutics, where his lab focuses on engineering large molecules to cross the BBB, as well as discovery and optimization of therapeutic antibodies and proteins. Adam previously worked in the Antibody Discovery and Engineering group at Takeda California. He received his postdoctoral training in bioengineering at Stanford University in the lab of Jennifer Cochran, and his Ph.D. and undergraduate training at Stanford and MIT, respectively.

Agenda Sessions